Human papillomavirus in head and neck tumors: epidemiological, molecular and clinical aspects.

Papillomavirus E5: the smallest oncoprotein with many functions. Mol Cancer (2011) 1.25

HPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress. Future Virol (2011) 1.10

High-risk human papillomavirus (HPV) screening and detection in healthy patient saliva samples: a pilot study. BMC Oral Health (2011) 0.98

Modifiable risk behaviors in patients with head and neck cancer. Cancer (2013) 0.89

Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med (2007) 16.39

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst (2008) 12.77

Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev (2005) 9.47

Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers. J Natl Cancer Inst (2008) 8.70

Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol (2008) 7.97

Human papillomavirus and oral cancer: the International Agency for Research on Cancer multicenter study. J Natl Cancer Inst (2003) 6.28

Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis (2009) 5.24

Molecular classification identifies a subset of human papillomavirus--associated oropharyngeal cancers with favorable prognosis. J Clin Oncol (2006) 4.66

Oral cancer risk in relation to sexual history and evidence of human papillomavirus infection. J Natl Cancer Inst (1998) 4.42

A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer (2007) 4.29

Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (2007) 4.20

Tongue and tonsil carcinoma: increasing trends in the U.S. population ages 20-44 years. Cancer (2005) 3.79

Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res (2003) 3.42

Human papillomavirus as a risk factor for the increase in incidence of tonsillar cancer. Int J Cancer (2006) 3.38

Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection. J Infect Dis (2000) 3.36

Inverse relationship between human papillomavirus-16 infection and disruptive p53 gene mutations in squamous cell carcinoma of the head and neck. Clin Cancer Res (2008) 2.66

Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer (2008) 2.62

Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancers. Int J Cancer (2004) 2.59

Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol (2004) 2.59

Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res (2009) 2.55

Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer (2001) 2.35

Human papillomavirus is a favourable prognostic factor in tonsillar cancer and its oncogenic role is supported by the expression of E6 and E7. Mol Oncol (2007) 2.27

Human papillomavirus (HPV) DNA in tonsillar cancer: clinical correlates, risk of relapse, and survival. Int J Cancer (2000) 2.17

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins. Cancer Sci (2007) 1.90

HPV infections and tonsillar carcinoma. J Clin Pathol (2004) 1.76

Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer (2003) 1.68

Human papillomavirus type 16 is episomal and a high viral load may be correlated to better prognosis in tonsillar cancer. Int J Cancer (2002) 1.66

Squamous cell carcinoma of the tonsils: a molecular analysis of HPV associations. Clin Cancer Res (2002) 1.57

Identification of biomarkers that distinguish human papillomavirus (HPV)-positive versus HPV-negative head and neck cancers in a mouse model. Proc Natl Acad Sci U S A (2006) 1.57

Human papillomavirus type 16 infection and squamous cell carcinoma of the head and neck in never-smokers: a matched pair analysis. Clin Cancer Res (2003) 1.55

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study. BMJ (1996) 1.51

Tonsillar and other upper aerodigestive tract cancers among cervical cancer patients and their husbands. Eur J Cancer Prev (2000) 1.42

Human papillomavirus seropositivity and risks of head and neck cancer. Int J Cancer (2007) 1.39

P16INK4a expression, human papillomavirus, and survival in head and neck cancer. Oral Oncol (2007) 1.30

Human papillomaviruses in head and neck cancer: 8 year-survival-analysis of 73 patients. Cancer Lett (2005) 1.22

Modern criteria to establish human cancer etiology. Cancer Res (2004) 1.18

HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol (2007) 1.13

Immunohistochemical detection of p53 protein accumulation in head and neck cancer: correlation with p53 gene alterations. Hum Pathol (1999) 1.11

Demographic and risk factors in patients with head and neck tumors. J Med Virol (2009) 1.10

Human papillomavirus-positive tonsillar carcinomas: a different tumor entity? Med Microbiol Immunol (2002) 1.08

HPV16 transmission between a couple with HPV-related head and neck cancer. Oral Oncol (2007) 0.98

Smoking impairs human papillomavirus (HPV) type 16 and 18 capsids antibody response following natural HPV infection. Scand J Infect Dis (2008) 0.98

HPV and other risk factors of oral cavity/oropharyngeal cancer in the Czech Republic. Oral Dis (2005) 0.92

Predicting residual neck disease in patients with oropharyngeal squamous cell carcinoma treated with radiation therapy: utility of p16 status. Arch Otolaryngol Head Neck Surg (2009) 0.90

Sequential combined tumorigenic effect of HPV-16 and chemical carcinogens. Carcinogenesis (1992) 0.89

Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. Arch Virol (2006) 0.88

Association between p53 and human papillomavirus in head and neck cancer survival. Cancer Epidemiol Biomarkers Prev (2008) 0.88

Prevalence of antibodies to human papillomaviruses in the general population of the Czech Republic. Int J Cancer (1998) 0.83

Humoral immune response against proteins E6 and E7 in cervical carcinoma patients positive for human papilloma virus type 16 during treatment and follow-up. Eur J Clin Microbiol Infect Dis (1999) 0.82

Cloning and genomic characterization of Felis domesticus papillomavirus type 1. Virology (2002) 1.19

High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination. J Virol (2015) 0.98

Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One (2013) 0.82